Annual CAPEX
$7.37 M
-$17.50 M-70.37%
31 December 2023
Summary:
Taysha Gene Therapies annual capital expenditures is currently $7.37 million, with the most recent change of -$17.50 million (-70.37%) on 31 December 2023. TSHA annual CAPEX is now -70.37% below its all-time high of $24.87 million, reached on 31 December 2022.TSHA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$35.00 K
-$166.00 K-82.59%
30 September 2024
Summary:
Taysha Gene Therapies quarterly capital expenditures is currently $35.00 thousand, with the most recent change of -$166.00 thousand (-82.59%) on 30 September 2024. Over the past year, it has dropped by -$3.46 million (-99.00%). TSHA quarterly CAPEX is now -99.10% below its all-time high of $3.90 million, reached on 31 March 2023.TSHA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$393.00 K
-$3.46 M-89.81%
30 September 2024
Summary:
Taysha Gene Therapies TTM capital expenditures is currently $393.00 thousand, with the most recent change of -$3.46 million (-89.81%) on 30 September 2024. Over the past year, it has dropped by -$9.27 million (-95.93%). TSHA TTM CAPEX is now -95.93% below its all-time high of $9.66 million, reached on 30 September 2023.TSHA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -70.4% | -99.0% | -95.9% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
TSHA CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -70.4% | at low | -99.1% | +172.9% | -95.9% | at low |
| 5 y | 5 years | -70.4% | at low | -99.1% | +172.9% | -95.9% | at low |
| alltime | all time | -70.4% | at low | -99.1% | +172.9% | -95.9% | at low |
Taysha Gene Therapies CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $35.00 K(-82.6%) | $393.00 K(-89.8%) |
| June 2024 | - | $201.00 K(+43.6%) | $3.86 M(+6.9%) |
| Mar 2024 | - | $140.00 K(+723.5%) | $3.61 M(-51.0%) |
| Dec 2023 | $7.37 M | $17.00 K(-99.5%) | $7.37 M(-23.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $3.50 M(-7391.7%) | $9.66 M(+56.8%) |
| June 2023 | - | -$48.00 K(-101.2%) | $6.16 M(-0.8%) |
| Mar 2023 | - | $3.90 M(+68.9%) | $6.21 M(+168.9%) |
| Dec 2022 | $24.87 M | $2.31 M | $2.31 M |
FAQ
- What is Taysha Gene Therapies annual capital expenditures?
- What is the all time high annual CAPEX for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual CAPEX year-on-year change?
- What is Taysha Gene Therapies quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly CAPEX year-on-year change?
- What is Taysha Gene Therapies TTM capital expenditures?
- What is the all time high TTM CAPEX for Taysha Gene Therapies?
- What is Taysha Gene Therapies TTM CAPEX year-on-year change?
What is Taysha Gene Therapies annual capital expenditures?
The current annual CAPEX of TSHA is $7.37 M
What is the all time high annual CAPEX for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual capital expenditures is $24.87 M
What is Taysha Gene Therapies annual CAPEX year-on-year change?
Over the past year, TSHA annual capital expenditures has changed by -$17.50 M (-70.37%)
What is Taysha Gene Therapies quarterly capital expenditures?
The current quarterly CAPEX of TSHA is $35.00 K
What is the all time high quarterly CAPEX for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly capital expenditures is $3.90 M
What is Taysha Gene Therapies quarterly CAPEX year-on-year change?
Over the past year, TSHA quarterly capital expenditures has changed by -$3.46 M (-99.00%)
What is Taysha Gene Therapies TTM capital expenditures?
The current TTM CAPEX of TSHA is $393.00 K
What is the all time high TTM CAPEX for Taysha Gene Therapies?
Taysha Gene Therapies all-time high TTM capital expenditures is $9.66 M
What is Taysha Gene Therapies TTM CAPEX year-on-year change?
Over the past year, TSHA TTM capital expenditures has changed by -$9.27 M (-95.93%)